Skip to main content

Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials.

Publication ,  Journal Article
Othus, M; Estey, EH; Garcia-Manero, G; Wood, BL; Stirewalt, DL; Godwin, JE; Weick, JK; Anderson, JE; Appelbaum, FR; Erba, HP; Walter, RB
Published in: Leukemia
February 2019

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Leukemia

DOI

EISSN

1476-5551

Publication Date

February 2019

Volume

33

Issue

2

Start / End Page

554 / 558

Location

England

Related Subject Headings

  • Young Adult
  • Treatment Outcome
  • Survival Rate
  • Remission Induction
  • Middle Aged
  • Male
  • Leukemia, Myeloid, Acute
  • Immunology
  • Humans
  • Gemtuzumab
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Othus, M., Estey, E. H., Garcia-Manero, G., Wood, B. L., Stirewalt, D. L., Godwin, J. E., … Walter, R. B. (2019). Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials. Leukemia, 33(2), 554–558. https://doi.org/10.1038/s41375-018-0274-y
Othus, Megan, Elihu H. Estey, Guillermo Garcia-Manero, Brent L. Wood, Derek L. Stirewalt, John E. Godwin, James K. Weick, et al. “Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials.Leukemia 33, no. 2 (February 2019): 554–58. https://doi.org/10.1038/s41375-018-0274-y.
Othus M, Estey EH, Garcia-Manero G, Wood BL, Stirewalt DL, Godwin JE, et al. Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials. Leukemia. 2019 Feb;33(2):554–8.
Othus, Megan, et al. “Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials.Leukemia, vol. 33, no. 2, Feb. 2019, pp. 554–58. Pubmed, doi:10.1038/s41375-018-0274-y.
Othus M, Estey EH, Garcia-Manero G, Wood BL, Stirewalt DL, Godwin JE, Weick JK, Anderson JE, Appelbaum FR, Erba HP, Walter RB. Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials. Leukemia. 2019 Feb;33(2):554–558.

Published In

Leukemia

DOI

EISSN

1476-5551

Publication Date

February 2019

Volume

33

Issue

2

Start / End Page

554 / 558

Location

England

Related Subject Headings

  • Young Adult
  • Treatment Outcome
  • Survival Rate
  • Remission Induction
  • Middle Aged
  • Male
  • Leukemia, Myeloid, Acute
  • Immunology
  • Humans
  • Gemtuzumab